A Clinical Efficacy and Safety Study of Insulin Glargine U300 in Chinese Adult Patients With Uncontrolled Type 2 Diabetes Mellitus With a 3-month Extension Period

NCT05002933 · clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
570
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Sanofi